Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-21-069962

Options or other derivatives

  • Chief Financial Officer acquired 17,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dekker C. Jeffrey Chief Financial Officer 2021-12-14 Grant or award · Stock Option (right to buy) +17,700 17,700 D
Loading xslF345X03/doc4.xml…